These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16749897)

  • 1. Combinatorial action of RUNX1 and PU.1 in the regulation of hematopoiesis.
    Saunthararajah Y; Boccuni P; Nucifora G
    Crit Rev Eukaryot Gene Expr; 2006; 16(2):183-92. PubMed ID: 16749897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
    Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
    J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
    Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
    Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RUNX1-PU.1 axis in the control of hematopoiesis.
    Imperato MR; Cauchy P; Obier N; Bonifer C
    Int J Hematol; 2015 Apr; 101(4):319-29. PubMed ID: 25749719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.
    Nerlov C; Graf T
    Genes Dev; 1998 Aug; 12(15):2403-12. PubMed ID: 9694804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
    Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
    J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation.
    Iwasaki H; Somoza C; Shigematsu H; Duprez EA; Iwasaki-Arai J; Mizuno S; Arinobu Y; Geary K; Zhang P; Dayaram T; Fenyus ML; Elf S; Chan S; Kastner P; Huettner CS; Murray R; Tenen DG; Akashi K
    Blood; 2005 Sep; 106(5):1590-600. PubMed ID: 15914556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
    Dakic A; Wu L; Nutt SL
    Trends Immunol; 2007 Mar; 28(3):108-14. PubMed ID: 17267285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin regulation by RUNX1.
    Lichtinger M; Hoogenkamp M; Krysinska H; Ingram R; Bonifer C
    Blood Cells Mol Dis; 2010 Apr; 44(4):287-90. PubMed ID: 20194037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Runx1, c-Myb, and C/EBPalpha couple differentiation to proliferation or growth arrest during hematopoiesis.
    Friedman AD
    J Cell Biochem; 2002; 86(4):624-9. PubMed ID: 12210729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.
    Yeamans C; Wang D; Paz-Priel I; Torbett BE; Tenen DG; Friedman AD
    Blood; 2007 Nov; 110(9):3136-42. PubMed ID: 17671233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factors that regulate growth and differentiation of myeloid cells.
    Nagamura-Inoue T; Tamura T; Ozato K
    Int Rev Immunol; 2001 Feb; 20(1):83-105. PubMed ID: 11342299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle and developmental control of hematopoiesis by Runx1.
    Friedman AD
    J Cell Physiol; 2009 Jun; 219(3):520-4. PubMed ID: 19235904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells.
    Challen GA; Goodell MA
    Exp Hematol; 2010 May; 38(5):403-16. PubMed ID: 20206228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.
    Lam K; Zhang DE
    Front Biosci (Landmark Ed); 2012 Jan; 17(3):1120-39. PubMed ID: 22201794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
    Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
    Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.
    Dahl R; Simon MC
    Blood Cells Mol Dis; 2003; 31(2):229-33. PubMed ID: 12972030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin A type 1B receptor gene and finally reducing C/EBPα expression.
    Lin HS; Gong JN; Su R; Chen MT; Song L; Shen C; Wang F; Ma YN; Zhao HL; Yu J; Li WW; Huang LX; Xu XH; Zhang JW
    J Leukoc Biol; 2014 Dec; 96(6):1023-35. PubMed ID: 25258381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of B lymphocyte and macrophage development by graded expression of PU.1.
    DeKoter RP; Singh H
    Science; 2000 May; 288(5470):1439-41. PubMed ID: 10827957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell emergence in the conceptus and the role of Runx1.
    Swiers G; de Bruijn M; Speck NA
    Int J Dev Biol; 2010; 54(6-7):1151-63. PubMed ID: 20711992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.